Leidos Health Names Tom Aikens Deputy Group President
Leidos Health Names Tom Aikens Deputy Group President
September 10, 2015
(Reston, Va.) September 10, 2015 – Leidos (NYSE: LDOS), a health, national security and engineering solutions company, announced the appointment of Tom Aikens as deputy group president of Leidos Health, effective September 1. Aikens will report to Health and Engineering Group President Jonathan Scholl. In his new role, Aikens will be responsible for managing profit, revenue growth, marketing, staffing, and general management to drive business objectives and achieve strategic milestones for the company’s commercial health business.
Aikens joined the company in 2006 and most recently served as Executive Vice President of Operations, where he worked closely with executive practice leaders to manage the oversight of go-live services, operation and legacy support, and international operations. Prior to joining Leidos, he held several senior level positions including Executive Vice President of provider operations for NDC Health, and Vice President and General Manager for McKesson Provider Technologies.
“Tom has a proven track record of solid health information technology leadership. His passion for the business, combined with strong operational knowledge and expertise, will help drive the growth and performance of Leidos Health,” said Leidos Health and Engineering Sector President Jon Scholl.
Aikens holds a B.S. in Science Business (cum laude) from Marywood University, an MBA from Webster University in St Louis, and has served in the U.S. Army. He has also served as a board member for the National Alliance on Mental Illness Greater Orlando.
About Leidos Health
Leidos Health is a leading healthcare IT consulting firm with deep clinical and technical expertise to support our customers in selecting, implementing, and optimizing information technology investments. Leidos Health offers a comprehensive range of technology services for health care providers – from vendor selection, strategy, design, implementation, and optimization, across all major electronic medical record systems. Our professional services help providers meet regulatory requirements, optimize technology for their clinical workflow, improve collections and reduce receivables, and keep data safe. For more information, visit www.leidoshealth.com.
About Leidos
Leidos is a science and technology solutions leader working to address some of the world’s toughest challenges in national security, health and engineering. The Company’s 19,000 employees support vital missions for our government and the commercial sector, develop innovative solutions to drive better outcomes and defend our Nation’s digital and physical infrastructure from ‘new world’ threats. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $5.06 billion for its fiscal year ended January 30, 2015. For more information, visit www.Leidos.com.
###
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s Annual Report on Form 10-K for the period ended January 30, 2015, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.
Aikens joined the company in 2006 and most recently served as Executive Vice President of Operations, where he worked closely with executive practice leaders to manage the oversight of go-live services, operation and legacy support, and international operations. Prior to joining Leidos, he held several senior level positions including Executive Vice President of provider operations for NDC Health, and Vice President and General Manager for McKesson Provider Technologies.
“Tom has a proven track record of solid health information technology leadership. His passion for the business, combined with strong operational knowledge and expertise, will help drive the growth and performance of Leidos Health,” said Leidos Health and Engineering Sector President Jon Scholl.
Aikens holds a B.S. in Science Business (cum laude) from Marywood University, an MBA from Webster University in St Louis, and has served in the U.S. Army. He has also served as a board member for the National Alliance on Mental Illness Greater Orlando.
About Leidos Health
Leidos Health is a leading healthcare IT consulting firm with deep clinical and technical expertise to support our customers in selecting, implementing, and optimizing information technology investments. Leidos Health offers a comprehensive range of technology services for health care providers – from vendor selection, strategy, design, implementation, and optimization, across all major electronic medical record systems. Our professional services help providers meet regulatory requirements, optimize technology for their clinical workflow, improve collections and reduce receivables, and keep data safe. For more information, visit www.leidoshealth.com.
About Leidos
Leidos is a science and technology solutions leader working to address some of the world’s toughest challenges in national security, health and engineering. The Company’s 19,000 employees support vital missions for our government and the commercial sector, develop innovative solutions to drive better outcomes and defend our Nation’s digital and physical infrastructure from ‘new world’ threats. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $5.06 billion for its fiscal year ended January 30, 2015. For more information, visit www.Leidos.com.
###
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s Annual Report on Form 10-K for the period ended January 30, 2015, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.